Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

475results about How to "Complicated process" patented technology

Personal choice biometric signature

InactiveUS7013030B2Improved high security method and systemEasy to useElectric signal transmission systemsImage analysisCombined useLinearity
A biometric method and system for personal authentication using sequences of partial fingerprint signatures provides a high security capability to various processes requiring positive identification of individuals. This approach is further enhanced by employing a frequency domain technique for calculating a Similarity Index of the partial fingerprint signatures. In a baseline usage, the sequential partial fingerprint sequence techniques augments sentinel systems for gaining access to restricted areas, and when used in combination with financial cards, offer a unique and greatly simplified means for authenticating or identifying individuals. A highly automated technique initially obtains four (illustratively) linear partial fingerprint signatures which serve as reference data against which later proffered candidate data in the form of at least two linear partial fingerprint signatures are compared for authentication. The particular two candidate signatures used and the sequence in which they are submitted are selected with the user's consent and serve as a PIN-like unique personal code. In an advanced embodiment, the same two candidate signatures in the chosen sequence are processed in a unique FFT / DFT process to produce a highly reliable Similarity Index to authenticate or verify the identity of individuals. The use of only partial fingerprint data greatly allays the concerns of widespread fingerprint dissemination by many individuals.
Owner:WONG JACOB Y +1

Method for determining deterioration of accumulator battery, method for measuring internal impedance of secondary battery, equipment for measuring internal impedance of secondary battery, equipment for determining deterioration of secondary battery, and power supply system

A method for determining deterioration of accumulator battery hooked up with loads in a system based on results of measuring internal resistances of an accumulator battery, the method comprising the steps of; predetermining as a specified temperature a temperature at which the deterioration of the accumulator battery is determined; calculating in advance temperature correction coefficients of the internal resistances from changes of the internal resistances depending on temperatures; predetermining resistance-voltage conversion factors to convert between the internal resistances at the specified temperature and terminal discharge voltages of the accumulator battery which are obtained at the specified temperature under a condition of flowing predetermined discharge currents from the accumulator battery; measuring the internal resistances of the accumulator battery and temperature of the accumulator battery at an internal resistance measurement; converting the measured internal resistance values into the internal resistance values at the specified temperature with use of the temperature correction coefficients of the internal resistances; converting the internal resistance values at the specified temperature into the terminal discharge voltage values of the accumulator battery at the specified temperature with use of the resistance-voltage conversion factors; and determining whether the accumulator battery is deteriorated or not by means of comparison of the terminal discharge voltage values of the accumulator battery at the specified temperature and a predetermined threshold value as a deterioration judgment standard.
Owner:FURUKAWA ELECTRIC CO LTD

Method and apparatus for screening, enrollment and management of patients in clinical trials

A computer-implemented method of tracking patient data in a clinical trial is provided. The clinical trial has one or more investigative sites which perform patient screening and enrollment for the clinical trial, one or more diagnostic sites which perform analysis on one or more patient diagnostic tests ordered by an investigative site and generate analysis results, and a centralized data center in electronic communication with the one or more investigative sites and the one or more diagnostic sites. Each investigative site is provided with a user interface display screen for allowing a user at the investigative site to enter data regarding patients who have been screened for the clinical trial and patients who have been enrolled in the clinical trial. The data from each of the investigative sites is electronically communicated to the centralized data center. Also, the analysis results from each of the diagnostic sites are electronically communicated to the centralized data center. The centralized data center consolidates the data and analysis results from each of the sites and provides one or more status reports regarding the patients for whom data and analysis results were received from the one or more investigative sites and the one or more diagnostic sites.
Owner:NUMODA TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products